Polychemotherapy for early breast cancer: an overview of the randomised trials
- 1 September 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 352 (9132), 930-942
- https://doi.org/10.1016/s0140-6736(98)03301-7
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast CancerJNCI Journal of the National Cancer Institute, 1997
- Overview of randomized perioperative polychemotherapy trials in women with early-stage breast cancer.Journal of Clinical Oncology, 1997
- Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group.Journal of Clinical Oncology, 1997
- Ovarian ablation in early breast cancer: overview of the randomised trialsThe Lancet, 1996
- Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized TrialsNew England Journal of Medicine, 1995
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Chemotherapy with or without oophorectomy in high-risk premenopausal patients with operable breast cancer.Journal of Clinical Oncology, 1985
- The Relation between Estrogen Receptors and Response Rate to Cytotoxic Chemotherapy in Metastatic Breast CancerNew England Journal of Medicine, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976